Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type |Pathology location|Pathology Description|
19-6-1|n/a,n/a|Sequence:1, Age:n/a,Type:none (controls),Quantity:0,Unit:grays,Application:External exposure, Remarks:n/a|25 (0 in ERA)|Dog|Dog, mongrel|n/a|Unknown|15-45 min, 10, 30, 105, 108, 115, 123, 130,748, 833, 921,1274, 1427 days
Pu-239 content in organs and excreta (radiometric data): lung, skeleton, liver, lymph glands, urine, feces. Micro distribution of Pu-239 in the structures of the eye
Clinical symptoms after plutonium inhalation in dogs: body mass;
Respiratory functions (frequency, depth and minute volume, oxygen saturation of arterial and venous blood, oxygen consumption and carbon dioxide excretion, respiration biomechanics, bronchus endoscopic picture);
Haemopoiesis (cells in peripheral blood and red bone marrow); circulatory system (peripheral arterial and venous pressure, extracellular liquid, heart mass parameters);
Eye pathology (ophthalmoscopic examination).
Late neoplastic and deterministic effects, average life span of dogs, causes of death according to the different clinical symptoms resulting from plutonium inhalation. 
|No information on individuals available for this study
19-6-2|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Co-60,Quantity:3.72,Unit:grays,Application:External exposure, Remarks:n/a|6 (0 in ERA)|Dog|Dog, mongrel|n/a|Unknown|4, 6, 9,13,16 days
Pu-239 content in organs and excreta (radiometric data): lung, skeleton, liver, lymph glands, urine, feces. Micro distribution of Pu-239 in the structures of the eye
Clinical symptoms after plutonium inhalation in dogs: body mass;
Respiratory functions (frequency, depth and minute volume, oxygen saturation of arterial and venous blood, oxygen consumption and carbon dioxide excretion, respiration biomechanics, bronchus endoscopic picture);
Haemopoiesis (cells in peripheral blood and red bone marrow); circulatory system (peripheral arterial and venous pressure, extracellular liquid, heart mass parameters);
Eye pathology (ophthalmoscopic examination).
Late neoplastic and deterministic effects, average life span of dogs, causes of death according to the different clinical symptoms resulting from plutonium inhalation. 
|No information on individuals available for this study
19-6-3|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Co-60,Quantity:1.86,Unit:grays,Application:External exposure, Remarks:n/a|13 (0 in ERA)|Dog|Dog, mongrel|n/a|Unknown|9, 11, 14, 17, 31, 58, 66, 78, 203, 303, 607, 779, 819 days
Pu-239 content in organs and excreta (radiometric data): lung, skeleton, liver, lymph glands, urine, feces. Micro distribution of Pu-239 in the structures of the eye
Clinical symptoms after plutonium inhalation in dogs: body mass;
Respiratory functions (frequency, depth and minute volume, oxygen saturation of arterial and venous blood, oxygen consumption and carbon dioxide excretion, respiration biomechanics, bronchus endoscopic picture);
Haemopoiesis (cells in peripheral blood and red bone marrow); circulatory system (peripheral arterial and venous pressure, extracellular liquid, heart mass parameters);
Eye pathology (ophthalmoscopic examination).
Late neoplastic and deterministic effects, average life span of dogs, causes of death according to the different clinical symptoms resulting from plutonium inhalation. 
|No information on individuals available for this study
19-6-4|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Co-60,Quantity:3.72,Unit:grays,Application:External exposure, Remarks:n/a|9 (0 in ERA)|Dog|Dog, mongrel|n/a|Unknown|life span 14.5 +/- 1.1 days
Pu-239 content in organs and excreta (radiometric data): lung, skeleton, liver, lymph glands, urine, feces. Micro distribution of Pu-239 in the structures of the eye
Clinical symptoms after plutonium inhalation in dogs: body mass;
Respiratory functions (frequency, depth and minute volume, oxygen saturation of arterial and venous blood, oxygen consumption and carbon dioxide excretion, respiration biomechanics, bronchus endoscopic picture);
Haemopoiesis (cells in peripheral blood and red bone marrow); circulatory system (peripheral arterial and venous pressure, extracellular liquid, heart mass parameters);
Eye pathology (ophthalmoscopic examination).
Late neoplastic and deterministic effects, average life span of dogs, causes of death according to the different clinical symptoms resulting from plutonium inhalation. 
|No information on individuals available for this study
19-6-5|n/a,n/a|Sequence:1, Age:n/a,Type:Pu-239 dioxide,Quantity:22,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:(AMD 0.065 µm, single inhalation 6 days after gamma-exposure|5 (0 in ERA)|Dog|Dog, mongrel|n/a|Unknown|life span 971 +/- 303 days
Pu-239 content in organs and excreta (radiometric data): lung, skeleton, liver, lymph glands, urine, feces. Micro distribution of Pu-239 in the structures of the eye
Clinical symptoms after plutonium inhalation in dogs: body mass;
Respiratory functions (frequency, depth and minute volume, oxygen saturation of arterial and venous blood, oxygen consumption and carbon dioxide excretion, respiration biomechanics, bronchus endoscopic picture);
Haemopoiesis (cells in peripheral blood and red bone marrow); circulatory system (peripheral arterial and venous pressure, extracellular liquid, heart mass parameters);
Eye pathology (ophthalmoscopic examination).
Late neoplastic and deterministic effects, average life span of dogs, causes of death according to the different clinical symptoms resulting from plutonium inhalation. 
|No information on individuals available for this study
19-6-6|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Co-60,Quantity:3.72,Unit:grays,Application:External exposure, Remarks:n/a|6 (0 in ERA)|Dog|Dog, mongrel|n/a|Unknown|life span15.8 +/- 3.0 days
Pu-239 content in organs and excreta (radiometric data): lung, skeleton, liver, lymph glands, urine, feces. Micro distribution of Pu-239 in the structures of the eye
Clinical symptoms after plutonium inhalation in dogs: body mass;
Respiratory functions (frequency, depth and minute volume, oxygen saturation of arterial and venous blood, oxygen consumption and carbon dioxide excretion, respiration biomechanics, bronchus endoscopic picture);
Haemopoiesis (cells in peripheral blood and red bone marrow); circulatory system (peripheral arterial and venous pressure, extracellular liquid, heart mass parameters);
Eye pathology (ophthalmoscopic examination).
Late neoplastic and deterministic effects, average life span of dogs, causes of death according to the different clinical symptoms resulting from plutonium inhalation. 
|No information on individuals available for this study
19-6-6|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:17,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:(AMD 0.065 µm, single inhalation 6 days after gamma-exposure|6 (0 in ERA)|Dog|Dog, mongrel|n/a|Unknown|life span15.8 +/- 3.0 days
Pu-239 content in organs and excreta (radiometric data): lung, skeleton, liver, lymph glands, urine, feces. Micro distribution of Pu-239 in the structures of the eye
Clinical symptoms after plutonium inhalation in dogs: body mass;
Respiratory functions (frequency, depth and minute volume, oxygen saturation of arterial and venous blood, oxygen consumption and carbon dioxide excretion, respiration biomechanics, bronchus endoscopic picture);
Haemopoiesis (cells in peripheral blood and red bone marrow); circulatory system (peripheral arterial and venous pressure, extracellular liquid, heart mass parameters);
Eye pathology (ophthalmoscopic examination).
Late neoplastic and deterministic effects, average life span of dogs, causes of death according to the different clinical symptoms resulting from plutonium inhalation. 
|No information on individuals available for this study
19-6-7|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Co-60,Quantity:1.86,Unit:grays,Application:External exposure, Remarks:n/a|6 (0 in ERA)|Dog|Dog, mongrel|n/a|Unknown|life span > 4 years (alive) 
Pu-239 content in organs and excreta (radiometric data): lung, skeleton, liver, lymph glands, urine, feces. Micro distribution of Pu-239 in the structures of the eye
Clinical symptoms after plutonium inhalation in dogs: body mass;
Respiratory functions (frequency, depth and minute volume, oxygen saturation of arterial and venous blood, oxygen consumption and carbon dioxide excretion, respiration biomechanics, bronchus endoscopic picture);
Haemopoiesis (cells in peripheral blood and red bone marrow); circulatory system (peripheral arterial and venous pressure, extracellular liquid, heart mass parameters);
Eye pathology (ophthalmoscopic examination).
Late neoplastic and deterministic effects, average life span of dogs, causes of death according to the different clinical symptoms resulting from plutonium inhalation. 
|No information on individuals available for this study
19-6-8|n/a,n/a|Sequence:1, Age:n/a,Type:Pu-239 dioxide,Quantity:64,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:(AMD 0.065 µm, single inhalation 6 days after gamma-exposure|8 (0 in ERA)|Dog|Dog, mongrel|n/a|Unknown|life span893 +/- 183 days
Pu-239 content in organs and excreta (radiometric data): lung, skeleton, liver, lymph glands, urine, feces. Micro distribution of Pu-239 in the structures of the eye
Clinical symptoms after plutonium inhalation in dogs: body mass;
Respiratory functions (frequency, depth and minute volume, oxygen saturation of arterial and venous blood, oxygen consumption and carbon dioxide excretion, respiration biomechanics, bronchus endoscopic picture);
Haemopoiesis (cells in peripheral blood and red bone marrow); circulatory system (peripheral arterial and venous pressure, extracellular liquid, heart mass parameters);
Eye pathology (ophthalmoscopic examination).
Late neoplastic and deterministic effects, average life span of dogs, causes of death according to the different clinical symptoms resulting from plutonium inhalation. 
|No information on individuals available for this study
19-6-9|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Co-60,Quantity:1.86,Unit:grays,Application:External exposure, Remarks:n/a|9 (0 in ERA)|Dog|Dog, mongrel|n/a|Unknown|life span  300 +/- 90 days 
Pu-239 content in organs and excreta (radiometric data): lung, skeleton, liver, lymph glands, urine, feces. Micro distribution of Pu-239 in the structures of the eye
Clinical symptoms after plutonium inhalation in dogs: body mass;
Respiratory functions (frequency, depth and minute volume, oxygen saturation of arterial and venous blood, oxygen consumption and carbon dioxide excretion, respiration biomechanics, bronchus endoscopic picture);
Haemopoiesis (cells in peripheral blood and red bone marrow); circulatory system (peripheral arterial and venous pressure, extracellular liquid, heart mass parameters);
Eye pathology (ophthalmoscopic examination).
Late neoplastic and deterministic effects, average life span of dogs, causes of death according to the different clinical symptoms resulting from plutonium inhalation. 
|No information on individuals available for this study
19-6-9|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:71,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:(AMD 0.065 µm, single inhalation 6 days after gamma-exposure|9 (0 in ERA)|Dog|Dog, mongrel|n/a|Unknown|life span  300 +/- 90 days 
Pu-239 content in organs and excreta (radiometric data): lung, skeleton, liver, lymph glands, urine, feces. Micro distribution of Pu-239 in the structures of the eye
Clinical symptoms after plutonium inhalation in dogs: body mass;
Respiratory functions (frequency, depth and minute volume, oxygen saturation of arterial and venous blood, oxygen consumption and carbon dioxide excretion, respiration biomechanics, bronchus endoscopic picture);
Haemopoiesis (cells in peripheral blood and red bone marrow); circulatory system (peripheral arterial and venous pressure, extracellular liquid, heart mass parameters);
Eye pathology (ophthalmoscopic examination).
Late neoplastic and deterministic effects, average life span of dogs, causes of death according to the different clinical symptoms resulting from plutonium inhalation. 
|No information on individuals available for this study
19-6-10|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Co-60,Quantity:0.93,Unit:grays,Application:External exposure, Remarks:n/a|3 (0 in ERA)|Dog|Dog, mongrel|n/a|Unknown|life span  >2.5 years (alive)
Pu-239 content in organs and excreta (radiometric data): lung, skeleton, liver, lymph glands, urine, feces. Micro distribution of Pu-239 in the structures of the eye
Clinical symptoms after plutonium inhalation in dogs: body mass;
Respiratory functions (frequency, depth and minute volume, oxygen saturation of arterial and venous blood, oxygen consumption and carbon dioxide excretion, respiration biomechanics, bronchus endoscopic picture);
Haemopoiesis (cells in peripheral blood and red bone marrow); circulatory system (peripheral arterial and venous pressure, extracellular liquid, heart mass parameters);
Eye pathology (ophthalmoscopic examination).
Late neoplastic and deterministic effects, average life span of dogs, causes of death according to the different clinical symptoms resulting from plutonium inhalation. 
|No information on individuals available for this study
19-6-11|n/a,n/a|Sequence:1, Age:n/a,Type:Pu-239 dioxide,Quantity:3.5,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:.7-7 kBq/kg(AMD 0.065 µm, single inhalation 6 days after gamma-exposure|5 (0 in ERA)|Dog|Dog, mongrel|n/a|Unknown|life span  >2.5 years (alive)
Pu-239 content in organs and excreta (radiometric data): lung, skeleton, liver, lymph glands, urine, feces. Micro distribution of Pu-239 in the structures of the eye
Clinical symptoms after plutonium inhalation in dogs: body mass;
Respiratory functions (frequency, depth and minute volume, oxygen saturation of arterial and venous blood, oxygen consumption and carbon dioxide excretion, respiration biomechanics, bronchus endoscopic picture);
Haemopoiesis (cells in peripheral blood and red bone marrow); circulatory system (peripheral arterial and venous pressure, extracellular liquid, heart mass parameters);
Eye pathology (ophthalmoscopic examination).
Late neoplastic and deterministic effects, average life span of dogs, causes of death according to the different clinical symptoms resulting from plutonium inhalation. 
|No information on individuals available for this study
19-6-12|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Co-60,Quantity:0.93,Unit:grays,Application:External exposure, Remarks:n/a|9 (0 in ERA)|Dog|Dog, mongrel|n/a|Unknown|life span  >2.5 years (alive)
Pu-239 content in organs and excreta (radiometric data): lung, skeleton, liver, lymph glands, urine, feces. Micro distribution of Pu-239 in the structures of the eye
Clinical symptoms after plutonium inhalation in dogs: body mass;
Respiratory functions (frequency, depth and minute volume, oxygen saturation of arterial and venous blood, oxygen consumption and carbon dioxide excretion, respiration biomechanics, bronchus endoscopic picture);
Haemopoiesis (cells in peripheral blood and red bone marrow); circulatory system (peripheral arterial and venous pressure, extracellular liquid, heart mass parameters);
Eye pathology (ophthalmoscopic examination).
Late neoplastic and deterministic effects, average life span of dogs, causes of death according to the different clinical symptoms resulting from plutonium inhalation. 
|No information on individuals available for this study
19-6-12|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:3.5,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:.7-7 kBq/kg(AMD 0.065 µm, single inhalation 6 days after gamma-exposure|9 (0 in ERA)|Dog|Dog, mongrel|n/a|Unknown|life span  >2.5 years (alive)
Pu-239 content in organs and excreta (radiometric data): lung, skeleton, liver, lymph glands, urine, feces. Micro distribution of Pu-239 in the structures of the eye
Clinical symptoms after plutonium inhalation in dogs: body mass;
Respiratory functions (frequency, depth and minute volume, oxygen saturation of arterial and venous blood, oxygen consumption and carbon dioxide excretion, respiration biomechanics, bronchus endoscopic picture);
Haemopoiesis (cells in peripheral blood and red bone marrow); circulatory system (peripheral arterial and venous pressure, extracellular liquid, heart mass parameters);
Eye pathology (ophthalmoscopic examination).
Late neoplastic and deterministic effects, average life span of dogs, causes of death according to the different clinical symptoms resulting from plutonium inhalation. 
|No information on individuals available for this study
19-6-13|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:3.72,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-13|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:9.25,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-14|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:1.86,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-14|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:9.25,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-15|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.93,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-15|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:9.25,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-16|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.46,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-16|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:9.25,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-17|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.23,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-17|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:9.25,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-18|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:3.72,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-18|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:37,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-19|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:1.86,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-19|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:37,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-20|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.93,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-20|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:37,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-21|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.46,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-21|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:37,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-22|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.23,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-22|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:37,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-23|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:3.72,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-23|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:92.5,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-24|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:1.86,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-24|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:92.5,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-25|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.93,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-25|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:92.5,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-26|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.46,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-26|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:92.5,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-27|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.23,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-27|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:92.5,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-28|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:3.72,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-29|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:1.86,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-30|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.93,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-31|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.46,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-32|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.23,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-33|n/a,n/a|Sequence:1, Age:n/a,Type:Pu-239 dioxide,Quantity:9.25,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-34|n/a,n/a|Sequence:1, Age:n/a,Type:Pu-239 dioxide,Quantity:37,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-35|n/a,n/a|Sequence:1, Age:n/a,Type:Pu-239 dioxide,Quantity:92.5,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|2 weeks, 1,2,3,6,12 months in vivo 
Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-36|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:3.72,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-36|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:9.25,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-37|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:1.86,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-37|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:9.25,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-38|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.93,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-38|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:9.25,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-39|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.46,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-39|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:9.25,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-40|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.23,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-40|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:9.25,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-41|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:3.72,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-41|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:18.5,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-42|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:1.86,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-42|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:18.5,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-43|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.93,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-43|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:18.5,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-44|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.46,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-44|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:18.5,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-45|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.23,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-45|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:18.5,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-46|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:3.72,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-46|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:37,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-47|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:1.86,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-47|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:37,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-48|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.93,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-48|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:37,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-49|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.46,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-49|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:37,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-50|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.23,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-50|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:37,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-51|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:3.72,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-51|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:92.5,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-52|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:1.86,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-52|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:92.5,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-53|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.93,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-53|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:92.5,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-54|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.46,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-54|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:92.5,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-55|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.23,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-55|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 dioxide,Quantity:92.5,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-56|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:3.72,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-57|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:1.86,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-58|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.93,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-59|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.46,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-60|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.23,Unit:grays,Application:External exposure, Remarks:n/a|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-61|n/a,n/a|Sequence:1, Age:n/a,Type:Pu-239 dioxide,Quantity:9.25,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-62|n/a,n/a|Sequence:1, Age:n/a,Type:Pu-239 dioxide,Quantity:18.5,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-63|n/a,n/a|Sequence:1, Age:n/a,Type:Pu-239 dioxide,Quantity:37,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-64|n/a,n/a|Sequence:1, Age:n/a,Type:Pu-239 dioxide,Quantity:92.5,Unit:kilobecquerels per kilogram animal,Application:Inhalation, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|At spontaneous death Body weight in vivo during 6 months after exposure. Number of erythrocytes and leucocytes in peripheral blood in vivo during 12 months after exposure. Mean life span until spontaneous death. 
|No information on individuals available for this study
19-6-65|n/a,n/a|Sequence:1, Age:n/a,Type:Pu-239 nitrate,Quantity:37,Unit:kilobecquerels per kilogram animal,Application:Injection, intratracheal, Remarks:immediately after exposure|20 (0 in ERA)|Rat|Rat Wistar|Female|Unknown|Pregnant female rats.
Pu-239 content in the organs of female rats during pregnancy and lactation (liver, skeleton, uterus, placenta, foetus) and of offspring (in the whole fall). Pu-239 transport to offspring through placenta and with mother milk. Estrous cycles and fertility of female rats. Offspring from exposed mother in the first and second generation: embryonic and foetal death, survival rate during the lactation period, body mass, brain volume, cell numbers in peripheral blood.
|No information on individuals available for this study
19-6-66|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.465,Unit:grays,Application:External exposure, Remarks:n/a|18 (0 in ERA)|Rat|Rat Wistar|Female|Unknown|Pregnant female rats.
Pu-239 content in the organs of female rats during pregnancy and lactation (liver, skeleton, uterus, placenta, foetus) and of offspring (in the whole fall). Pu-239 transport to offspring through placenta and with mother milk. Estrous cycles and fertility of female rats. Offspring from exposed mother in the first and second generation: embryonic and foetal death, survival rate during the lactation period, body mass, brain volume, cell numbers in peripheral blood.
|No information on individuals available for this study
19-6-66|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 nitrate,Quantity:37,Unit:kilobecquerels per kilogram animal,Application:Injection, intratracheal, Remarks:immediately after exposure|18 (0 in ERA)|Rat|Rat Wistar|Female|Unknown|Pregnant female rats.
Pu-239 content in the organs of female rats during pregnancy and lactation (liver, skeleton, uterus, placenta, foetus) and of offspring (in the whole fall). Pu-239 transport to offspring through placenta and with mother milk. Estrous cycles and fertility of female rats. Offspring from exposed mother in the first and second generation: embryonic and foetal death, survival rate during the lactation period, body mass, brain volume, cell numbers in peripheral blood.
|No information on individuals available for this study
19-6-67|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.93,Unit:grays,Application:External exposure, Remarks:n/a|19 (0 in ERA)|Rat|Rat Wistar|Female|Unknown|Pregnant female rats.
Pu-239 content in the organs of female rats during pregnancy and lactation (liver, skeleton, uterus, placenta, foetus) and of offspring (in the whole fall). Pu-239 transport to offspring through placenta and with mother milk. Estrous cycles and fertility of female rats. Offspring from exposed mother in the first and second generation: embryonic and foetal death, survival rate during the lactation period, body mass, brain volume, cell numbers in peripheral blood.
|No information on individuals available for this study
19-6-67|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 nitrate,Quantity:37,Unit:kilobecquerels per kilogram animal,Application:Injection, intratracheal, Remarks:immediately after exposure|19 (0 in ERA)|Rat|Rat Wistar|Female|Unknown|Pregnant female rats.
Pu-239 content in the organs of female rats during pregnancy and lactation (liver, skeleton, uterus, placenta, foetus) and of offspring (in the whole fall). Pu-239 transport to offspring through placenta and with mother milk. Estrous cycles and fertility of female rats. Offspring from exposed mother in the first and second generation: embryonic and foetal death, survival rate during the lactation period, body mass, brain volume, cell numbers in peripheral blood.
|No information on individuals available for this study
19-6-68|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:3.72,Unit:grays,Application:External exposure, Remarks:n/a|19 (0 in ERA)|Rat|Rat Wistar|Female|Unknown|Pregnant female rats.
Pu-239 content in the organs of female rats during pregnancy and lactation (liver, skeleton, uterus, placenta, foetus) and of offspring (in the whole fall). Pu-239 transport to offspring through placenta and with mother milk. Estrous cycles and fertility of female rats. Offspring from exposed mother in the first and second generation: embryonic and foetal death, survival rate during the lactation period, body mass, brain volume, cell numbers in peripheral blood.
|No information on individuals available for this study
19-6-68|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 nitrate,Quantity:37,Unit:kilobecquerels per kilogram animal,Application:Injection, intratracheal, Remarks:immediately after exposure|19 (0 in ERA)|Rat|Rat Wistar|Female|Unknown|Pregnant female rats.
Pu-239 content in the organs of female rats during pregnancy and lactation (liver, skeleton, uterus, placenta, foetus) and of offspring (in the whole fall). Pu-239 transport to offspring through placenta and with mother milk. Estrous cycles and fertility of female rats. Offspring from exposed mother in the first and second generation: embryonic and foetal death, survival rate during the lactation period, body mass, brain volume, cell numbers in peripheral blood.
|No information on individuals available for this study
19-6-69|n/a,n/a|Sequence:1, Age:n/a,Type:none (controls),Quantity:0,Unit:grays,Application:External exposure, Remarks:n/a|10 (0 in ERA)|Rat|Rat Wistar|Female|Unknown|Lactating female rats.
Pu-239 content in the organs of female rats during pregnancy and lactation (liver, skeleton, uterus, placenta, foetus) and of offspring (in the whole fall). Pu-239 transport to offspring through placenta and with mother milk. Estrous cycles and fertility of female rats. Offspring from exposed mother in the first and second generation: embryonic and foetal death, survival rate during the lactation period, body mass, brain volume, cell numbers in peripheral blood.
|No information on individuals available for this study
19-6-70|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.47,Unit:grays,Application:External exposure, Remarks:n/a|10 (0 in ERA)|Rat|Rat Wistar|Female|Unknown|Lactating female rats.
Pu-239 content in the organs of female rats during pregnancy and lactation (liver, skeleton, uterus, placenta, foetus) and of offspring (in the whole fall). Pu-239 transport to offspring through placenta and with mother milk. Estrous cycles and fertility of female rats. Offspring from exposed mother in the first and second generation: embryonic and foetal death, survival rate during the lactation period, body mass, brain volume, cell numbers in peripheral blood.
|No information on individuals available for this study
19-6-70|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 nitrate,Quantity:37,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:immediately after exposure|10 (0 in ERA)|Rat|Rat Wistar|Female|Unknown|Lactating female rats.
Pu-239 content in the organs of female rats during pregnancy and lactation (liver, skeleton, uterus, placenta, foetus) and of offspring (in the whole fall). Pu-239 transport to offspring through placenta and with mother milk. Estrous cycles and fertility of female rats. Offspring from exposed mother in the first and second generation: embryonic and foetal death, survival rate during the lactation period, body mass, brain volume, cell numbers in peripheral blood.
|No information on individuals available for this study
19-6-71|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.93,Unit:grays,Application:External exposure, Remarks:n/a|10 (0 in ERA)|Rat|Rat Wistar|Female|Unknown|Lactating female rats.
Pu-239 content in the organs of female rats during pregnancy and lactation (liver, skeleton, uterus, placenta, foetus) and of offspring (in the whole fall). Pu-239 transport to offspring through placenta and with mother milk. Estrous cycles and fertility of female rats. Offspring from exposed mother in the first and second generation: embryonic and foetal death, survival rate during the lactation period, body mass, brain volume, cell numbers in peripheral blood.
|No information on individuals available for this study
19-6-71|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 nitrate,Quantity:37,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:immediately after exposure|10 (0 in ERA)|Rat|Rat Wistar|Female|Unknown|Lactating female rats.
Pu-239 content in the organs of female rats during pregnancy and lactation (liver, skeleton, uterus, placenta, foetus) and of offspring (in the whole fall). Pu-239 transport to offspring through placenta and with mother milk. Estrous cycles and fertility of female rats. Offspring from exposed mother in the first and second generation: embryonic and foetal death, survival rate during the lactation period, body mass, brain volume, cell numbers in peripheral blood.
|No information on individuals available for this study
19-6-72|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:3.72,Unit:grays,Application:External exposure, Remarks:n/a|10 (0 in ERA)|Rat|Rat Wistar|Female|Unknown|Lactating female rats.
Pu-239 content in the organs of female rats during pregnancy and lactation (liver, skeleton, uterus, placenta, foetus) and of offspring (in the whole fall). Pu-239 transport to offspring through placenta and with mother milk. Estrous cycles and fertility of female rats. Offspring from exposed mother in the first and second generation: embryonic and foetal death, survival rate during the lactation period, body mass, brain volume, cell numbers in peripheral blood.
|No information on individuals available for this study
19-6-72|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 nitrate,Quantity:37,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:immediately after exposure|10 (0 in ERA)|Rat|Rat Wistar|Female|Unknown|Lactating female rats.
Pu-239 content in the organs of female rats during pregnancy and lactation (liver, skeleton, uterus, placenta, foetus) and of offspring (in the whole fall). Pu-239 transport to offspring through placenta and with mother milk. Estrous cycles and fertility of female rats. Offspring from exposed mother in the first and second generation: embryonic and foetal death, survival rate during the lactation period, body mass, brain volume, cell numbers in peripheral blood.
|No information on individuals available for this study
19-6-73|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.465,Unit:grays,Application:External exposure, Remarks:n/a|40 (0 in ERA)|Rat|Rat Wistar|Both|Unknown|Offspring from exposed mothers in 1st and 2nd generation 
Pu-239 content in the organs of female rats during pregnancy and lactation (liver, skeleton, uterus, placenta, foetus) and of offspring (in the whole fall). Pu-239 transport to offspring through placenta and with mother milk. Estrous cycles and fertility of female rats. Offspring from exposed mother in the first and second generation: embryonic and foetal death, survival rate during the lactation period, body mass, brain volume, cell numbers in peripheral blood.
|No information on individuals available for this study
19-6-73|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 nitrate,Quantity:37,Unit:kilobecquerels per kilogram animal,Application:Injection, intratracheal, Remarks:immediately after exposure|40 (0 in ERA)|Rat|Rat Wistar|Both|Unknown|Offspring from exposed mothers in 1st and 2nd generation 
Pu-239 content in the organs of female rats during pregnancy and lactation (liver, skeleton, uterus, placenta, foetus) and of offspring (in the whole fall). Pu-239 transport to offspring through placenta and with mother milk. Estrous cycles and fertility of female rats. Offspring from exposed mother in the first and second generation: embryonic and foetal death, survival rate during the lactation period, body mass, brain volume, cell numbers in peripheral blood.
|No information on individuals available for this study
19-6-74|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.93,Unit:grays,Application:External exposure, Remarks:n/a|40 (0 in ERA)|Rat|Rat Wistar|Both|Unknown|Offspring from exposed mothers in 1st and 2nd generation 
Pu-239 content in the organs of female rats during pregnancy and lactation (liver, skeleton, uterus, placenta, foetus) and of offspring (in the whole fall). Pu-239 transport to offspring through placenta and with mother milk. Estrous cycles and fertility of female rats. Offspring from exposed mother in the first and second generation: embryonic and foetal death, survival rate during the lactation period, body mass, brain volume, cell numbers in peripheral blood.
|No information on individuals available for this study
19-6-74|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 nitrate,Quantity:37,Unit:kilobecquerels per kilogram animal,Application:Injection, intratracheal, Remarks:immediately after exposure|40 (0 in ERA)|Rat|Rat Wistar|Both|Unknown|Offspring from exposed mothers in 1st and 2nd generation 
Pu-239 content in the organs of female rats during pregnancy and lactation (liver, skeleton, uterus, placenta, foetus) and of offspring (in the whole fall). Pu-239 transport to offspring through placenta and with mother milk. Estrous cycles and fertility of female rats. Offspring from exposed mother in the first and second generation: embryonic and foetal death, survival rate during the lactation period, body mass, brain volume, cell numbers in peripheral blood.
|No information on individuals available for this study
19-6-75|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:1.86,Unit:grays,Application:External exposure, Remarks:n/a|40 (0 in ERA)|Rat|Rat Wistar|Both|Unknown|Offspring from exposed mothers in 1st and 2nd generation 
Pu-239 content in the organs of female rats during pregnancy and lactation (liver, skeleton, uterus, placenta, foetus) and of offspring (in the whole fall). Pu-239 transport to offspring through placenta and with mother milk. Estrous cycles and fertility of female rats. Offspring from exposed mother in the first and second generation: embryonic and foetal death, survival rate during the lactation period, body mass, brain volume, cell numbers in peripheral blood.
|No information on individuals available for this study
19-6-75|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 nitrate,Quantity:37,Unit:kilobecquerels per kilogram animal,Application:Injection, intratracheal, Remarks:immediately after exposure|40 (0 in ERA)|Rat|Rat Wistar|Both|Unknown|Offspring from exposed mothers in 1st and 2nd generation 
Pu-239 content in the organs of female rats during pregnancy and lactation (liver, skeleton, uterus, placenta, foetus) and of offspring (in the whole fall). Pu-239 transport to offspring through placenta and with mother milk. Estrous cycles and fertility of female rats. Offspring from exposed mother in the first and second generation: embryonic and foetal death, survival rate during the lactation period, body mass, brain volume, cell numbers in peripheral blood.
|No information on individuals available for this study
19-6-76|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:3.72,Unit:grays,Application:External exposure, Remarks:n/a|120 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Sacrifice:1, 6, 14, 30, 90,180, 270, 360, 525 days and 12-17 months after spontaneous death  3-12 rats for each period.
Biochemistry: DNA and RNA content in thymus and spleen, activity of alanine and asparagine aminotransferases in blood serum, activity of alkaline phosphatase in bones, bone tumors, liver and blood serum. 
Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data); average life span|No information on individuals available for this study
19-6-76|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 nitrate,Quantity:92.5,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:6 d after gamma exposure|120 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Sacrifice:1, 6, 14, 30, 90,180, 270, 360, 525 days and 12-17 months after spontaneous death  3-12 rats for each period.
Biochemistry: DNA and RNA content in thymus and spleen, activity of alanine and asparagine aminotransferases in blood serum, activity of alkaline phosphatase in bones, bone tumors, liver and blood serum. 
Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data); average life span|No information on individuals available for this study
19-6-77|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:1.86,Unit:grays,Application:External exposure, Remarks:n/a|120 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Sacrifice:1, 6, 14, 30, 90,180, 270, 360, 525 days and 12-17 months after spontaneous death  3-12 rats for each period.
Biochemistry: DNA and RNA content in thymus and spleen, activity of alanine and asparagine aminotransferases in blood serum, activity of alkaline phosphatase in bones, bone tumors, liver and blood serum. 
Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data); average life span|No information on individuals available for this study
19-6-77|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 nitrate,Quantity:46.25,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:6 d after gamma exposure|120 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Sacrifice:1, 6, 14, 30, 90,180, 270, 360, 525 days and 12-17 months after spontaneous death  3-12 rats for each period.
Biochemistry: DNA and RNA content in thymus and spleen, activity of alanine and asparagine aminotransferases in blood serum, activity of alkaline phosphatase in bones, bone tumors, liver and blood serum. 
Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data); average life span|No information on individuals available for this study
19-6-78|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:3.72,Unit:grays,Application:External exposure, Remarks:n/a|120 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Sacrifice:1, 6, 14, 30, 90,180, 270, 360, 525 days and 12-17 months after spontaneous death  3-12 rats for each period.
Biochemistry: DNA and RNA content in thymus and spleen, activity of alanine and asparagine aminotransferases in blood serum, activity of alkaline phosphatase in bones, bone tumors, liver and blood serum. 
Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data); average life span|No information on individuals available for this study
19-6-79|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:1.86,Unit:grays,Application:External exposure, Remarks:n/a|120 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Sacrifice:1, 6, 14, 30, 90,180, 270, 360, 525 days and 12-17 months after spontaneous death  3-12 rats for each period.
Biochemistry: DNA and RNA content in thymus and spleen, activity of alanine and asparagine aminotransferases in blood serum, activity of alkaline phosphatase in bones, bone tumors, liver and blood serum. 
Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data); average life span|No information on individuals available for this study
19-6-80|n/a,n/a|Sequence:1, Age:n/a,Type:Pu-239 nitrate,Quantity:92.5,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:6 d after gamma exposure|120 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Sacrifice:1, 6, 14, 30, 90,180, 270, 360, 525 days and 12-17 months after spontaneous death  3-12 rats for each period.
Biochemistry: DNA and RNA content in thymus and spleen, activity of alanine and asparagine aminotransferases in blood serum, activity of alkaline phosphatase in bones, bone tumors, liver and blood serum. 
Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data); average life span|No information on individuals available for this study
19-6-81|n/a,n/a|Sequence:1, Age:n/a,Type:Pu-239 nitrate,Quantity:46.25,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:6 d after gamma exposure|120 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Sacrifice:1, 6, 14, 30, 90,180, 270, 360, 525 days and 12-17 months after spontaneous death  3-12 rats for each period.
Biochemistry: DNA and RNA content in thymus and spleen, activity of alanine and asparagine aminotransferases in blood serum, activity of alkaline phosphatase in bones, bone tumors, liver and blood serum. 
Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data); average life span|No information on individuals available for this study
19-6-82|n/a,n/a|Sequence:1, Age:n/a,Type:none (controls),Quantity:0,Unit:grays,Application:External exposure, Remarks:n/a|120 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Sacrifice:1, 6, 14, 30, 90,180, 270, 360, 525 days and 12-17 months after spontaneous death  3-12 rats for each period.
Biochemistry: DNA and RNA content in thymus and spleen, activity of alanine and asparagine aminotransferases in blood serum, activity of alkaline phosphatase in bones, bone tumors, liver and blood serum. 
Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data); average life span|No information on individuals available for this study
19-6-83|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:3.72,Unit:grays,Application:External exposure, Remarks:n/a|92 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Biochemistry: DNA and RNA content in thymus and spleen, activity of alanine and asparagine aminotransferases in blood serum, activity of alkaline phosphatase in bones, bone tumors, liver and blood serum. 
Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data); average life span|No information on individuals available for this study
19-6-84|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:1.86,Unit:grays,Application:External exposure, Remarks:n/a|72 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Biochemistry: DNA and RNA content in thymus and spleen, activity of alanine and asparagine aminotransferases in blood serum, activity of alkaline phosphatase in bones, bone tumors, liver and blood serum. 
Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data); average life span|No information on individuals available for this study
19-6-85|n/a,n/a|Sequence:1, Age:n/a,Type:Pu-239 nitrate,Quantity:77.7,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:n/a|94 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Biochemistry: DNA and RNA content in thymus and spleen, activity of alanine and asparagine aminotransferases in blood serum, activity of alkaline phosphatase in bones, bone tumors, liver and blood serum. 
Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data); average life span|No information on individuals available for this study
19-6-86|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:3.72,Unit:grays,Application:External exposure, Remarks:n/a|88 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Biochemistry: DNA and RNA content in thymus and spleen, activity of alanine and asparagine aminotransferases in blood serum, activity of alkaline phosphatase in bones, bone tumors, liver and blood serum. 
Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data); average life span|No information on individuals available for this study
19-6-86|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 nitrate,Quantity:92.5,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:6 d after gamma exposure|88 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Biochemistry: DNA and RNA content in thymus and spleen, activity of alanine and asparagine aminotransferases in blood serum, activity of alkaline phosphatase in bones, bone tumors, liver and blood serum. 
Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data); average life span|No information on individuals available for this study
19-6-87|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:1.86,Unit:grays,Application:External exposure, Remarks:n/a|98 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Biochemistry: DNA and RNA content in thymus and spleen, activity of alanine and asparagine aminotransferases in blood serum, activity of alkaline phosphatase in bones, bone tumors, liver and blood serum. 
Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data); average life span|No information on individuals available for this study
19-6-88|n/a,n/a|Sequence:1, Age:n/a,Type:none (controls),Quantity:0,Unit:grays,Application:External exposure, Remarks:n/a|192 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Biochemistry: DNA and RNA content in thymus and spleen, activity of alanine and asparagine aminotransferases in blood serum, activity of alkaline phosphatase in bones, bone tumors, liver and blood serum. 
Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data); average life span|No information on individuals available for this study
19-6-89|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:1.86,Unit:grays,Application:External exposure, Remarks:n/a|50 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Sacrifice-1, 3, 7 days, 0.5, 1, 2, 3, 4, 6, 10, 12 months (to investigate respiration and haemopoietic systems) and after spontaneous death (to estimate life span)
Respiratory functions: frequency, depth and minute volume, oxygen saturation of blood, oxygen consumption. 
Hemopoiesis: cells in peripheral blood and red bone marrow. Mass of circulating blood, volume of total erythrocytes volume, Fe-59 uptake by erythrocytes.
Late effects: mean life span of rats, LD50/480 (the dose from which 50% of rats die within 480 days after exposure).
|No information on individuals available for this study
19-6-90|n/a,n/a|Sequence:1, Age:n/a,Type:Pu-239 nitrate,Quantity:0.02,Unit:kilobecquerels per kilogram animal,Application:Injection, intratracheal, Remarks:6 d after gamma exposure|42 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Sacrifice-1, 3, 7 days, 0.5, 1, 2, 3, 4, 6, 10, 12 months (to investigate respiration and haemopoietic systems) and after spontaneous death (to estimate life span)
Respiratory functions: frequency, depth and minute volume, oxygen saturation of blood, oxygen consumption. 
Hemopoiesis: cells in peripheral blood and red bone marrow. Mass of circulating blood, volume of total erythrocytes volume, Fe-59 uptake by erythrocytes.
Late effects: mean life span of rats, LD50/480 (the dose from which 50% of rats die within 480 days after exposure).
|No information on individuals available for this study
19-6-91|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:1.86,Unit:grays,Application:External exposure, Remarks:n/a|38 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Sacrifice-1, 3, 7 days, 0.5, 1, 2, 3, 4, 6, 10, 12 months (to investigate respiration and haemopoietic systems) and after spontaneous death (to estimate life span)
Respiratory functions: frequency, depth and minute volume, oxygen saturation of blood, oxygen consumption. 
Hemopoiesis: cells in peripheral blood and red bone marrow. Mass of circulating blood, volume of total erythrocytes volume, Fe-59 uptake by erythrocytes.
Late effects: mean life span of rats, LD50/480 (the dose from which 50% of rats die within 480 days after exposure).
|No information on individuals available for this study
19-6-91|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 nitrate,Quantity:0.02,Unit:kilobecquerels per kilogram animal,Application:Injection, intratracheal, Remarks:6 d after gamma exposure|38 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Sacrifice-1, 3, 7 days, 0.5, 1, 2, 3, 4, 6, 10, 12 months (to investigate respiration and haemopoietic systems) and after spontaneous death (to estimate life span)
Respiratory functions: frequency, depth and minute volume, oxygen saturation of blood, oxygen consumption. 
Hemopoiesis: cells in peripheral blood and red bone marrow. Mass of circulating blood, volume of total erythrocytes volume, Fe-59 uptake by erythrocytes.
Late effects: mean life span of rats, LD50/480 (the dose from which 50% of rats die within 480 days after exposure).
|No information on individuals available for this study
19-6-92|n/a,n/a|Sequence:1, Age:n/a,Type:none (controls),Quantity:0,Unit:grays,Application:External exposure, Remarks:n/a|100 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Sacrifice-1, 3, 7 days, 0.5, 1, 2, 3, 4, 6, 10, 12 months (to investigate respiration and haemopoietic systems) and after spontaneous death (to estimate life span)
Respiratory functions: frequency, depth and minute volume, oxygen saturation of blood, oxygen consumption. 
Hemopoiesis: cells in peripheral blood and red bone marrow. Mass of circulating blood, volume of total erythrocytes volume, Fe-59 uptake by erythrocytes.
Late effects: mean life span of rats, LD50/480 (the dose from which 50% of rats die within 480 days after exposure).
|No information on individuals available for this study
19-6-93|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:1.86,Unit:grays,Application:External exposure, Remarks:n/a|48 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Sacrifice-1, 3, 7 days, 0.5, 1, 2, 3, 4, 6, 10, 12 months (to investigate respiration and haemopoietic systems) and after spontaneous death (to estimate life span)
Respiratory functions: frequency, depth and minute volume, oxygen saturation of blood, oxygen consumption. 
Hemopoiesis: cells in peripheral blood and red bone marrow. Mass of circulating blood, volume of total erythrocytes volume, Fe-59 uptake by erythrocytes.
Late effects: mean life span of rats, LD50/480 (the dose from which 50% of rats die within 480 days after exposure).
|No information on individuals available for this study
19-6-93|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 nitrate,Quantity:0.02,Unit:kilobecquerels per kilogram animal,Application:Injection, intratracheal, Remarks:6 d after gamma exposure|48 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Sacrifice-1, 3, 7 days, 0.5, 1, 2, 3, 4, 6, 10, 12 months (to investigate respiration and haemopoietic systems) and after spontaneous death (to estimate life span)
Respiratory functions: frequency, depth and minute volume, oxygen saturation of blood, oxygen consumption. 
Hemopoiesis: cells in peripheral blood and red bone marrow. Mass of circulating blood, volume of total erythrocytes volume, Fe-59 uptake by erythrocytes.
Late effects: mean life span of rats, LD50/480 (the dose from which 50% of rats die within 480 days after exposure).
|No information on individuals available for this study
19-6-94|n/a,n/a|Sequence:1, Age:n/a,Type:Pu-239 nitrate,Quantity:0.02,Unit:kilobecquerels per kilogram animal,Application:Injection, intratracheal, Remarks:6 d after gamma exposure|47 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Sacrifice-1, 3, 7 days, 0.5, 1, 2, 3, 4, 6, 10, 12 months (to investigate respiration and haemopoietic systems) and after spontaneous death (to estimate life span)
Respiratory functions: frequency, depth and minute volume, oxygen saturation of blood, oxygen consumption. 
Hemopoiesis: cells in peripheral blood and red bone marrow. Mass of circulating blood, volume of total erythrocytes volume, Fe-59 uptake by erythrocytes.
Late effects: mean life span of rats, LD50/480 (the dose from which 50% of rats die within 480 days after exposure).
|No information on individuals available for this study
19-6-95|n/a,n/a|Sequence:1, Age:n/a,Type:Pu-239 nitrate,Quantity:1.6,Unit:kilobecquerels per kilogram animal,Application:Injection, intratracheal, Remarks:6 d after gamma exposure|49 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Sacrifice-1, 3, 7 days, 0.5, 1, 2, 3, 4, 6, 10, 12 months (to investigate respiration and haemopoietic systems) and after spontaneous death (to estimate life span)
Respiratory functions: frequency, depth and minute volume, oxygen saturation of blood, oxygen consumption. 
Hemopoiesis: cells in peripheral blood and red bone marrow. Mass of circulating blood, volume of total erythrocytes volume, Fe-59 uptake by erythrocytes.
Late effects: mean life span of rats, LD50/480 (the dose from which 50% of rats die within 480 days after exposure).
|No information on individuals available for this study
19-6-96|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:1.86,Unit:grays,Application:External exposure, Remarks:n/a|47 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Sacrifice-1, 3, 7 days, 0.5, 1, 2, 3, 4, 6, 10, 12 months (to investigate respiration and haemopoietic systems) and after spontaneous death (to estimate life span)
Respiratory functions: frequency, depth and minute volume, oxygen saturation of blood, oxygen consumption. 
Hemopoiesis: cells in peripheral blood and red bone marrow. Mass of circulating blood, volume of total erythrocytes volume, Fe-59 uptake by erythrocytes.
Late effects: mean life span of rats, LD50/480 (the dose from which 50% of rats die within 480 days after exposure).
|No information on individuals available for this study
19-6-96|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 nitrate,Quantity:1.6,Unit:kilobecquerels per kilogram animal,Application:Injection, intratracheal, Remarks:6 d after gamma exposure|47 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Sacrifice-1, 3, 7 days, 0.5, 1, 2, 3, 4, 6, 10, 12 months (to investigate respiration and haemopoietic systems) and after spontaneous death (to estimate life span)
Respiratory functions: frequency, depth and minute volume, oxygen saturation of blood, oxygen consumption. 
Hemopoiesis: cells in peripheral blood and red bone marrow. Mass of circulating blood, volume of total erythrocytes volume, Fe-59 uptake by erythrocytes.
Late effects: mean life span of rats, LD50/480 (the dose from which 50% of rats die within 480 days after exposure).
|No information on individuals available for this study
19-6-97|n/a,n/a|Sequence:1, Age:n/a,Type:Pu-239 nitrate,Quantity:13,Unit:kilobecquerels per kilogram animal,Application:Injection, intratracheal, Remarks:6 d after gamma exposure|46 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Sacrifice-1, 3, 7 days, 0.5, 1, 2, 3, 4, 6, 10, 12 months (to investigate respiration and haemopoietic systems) and after spontaneous death (to estimate life span)
Respiratory functions: frequency, depth and minute volume, oxygen saturation of blood, oxygen consumption. 
Hemopoiesis: cells in peripheral blood and red bone marrow. Mass of circulating blood, volume of total erythrocytes volume, Fe-59 uptake by erythrocytes.
Late effects: mean life span of rats, LD50/480 (the dose from which 50% of rats die within 480 days after exposure).
|No information on individuals available for this study
19-6-98|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:1.86,Unit:grays,Application:External exposure, Remarks:n/a|41 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Sacrifice-1, 3, 7 days, 0.5, 1, 2, 3, 4, 6, 10, 12 months (to investigate respiration and haemopoietic systems) and after spontaneous death (to estimate life span)
Respiratory functions: frequency, depth and minute volume, oxygen saturation of blood, oxygen consumption. 
Hemopoiesis: cells in peripheral blood and red bone marrow. Mass of circulating blood, volume of total erythrocytes volume, Fe-59 uptake by erythrocytes.
Late effects: mean life span of rats, LD50/480 (the dose from which 50% of rats die within 480 days after exposure).
|No information on individuals available for this study
19-6-98|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 nitrate,Quantity:13,Unit:kilobecquerels per kilogram animal,Application:Injection, intratracheal, Remarks:6 d after gamma exposure|41 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Sacrifice-1, 3, 7 days, 0.5, 1, 2, 3, 4, 6, 10, 12 months (to investigate respiration and haemopoietic systems) and after spontaneous death (to estimate life span)
Respiratory functions: frequency, depth and minute volume, oxygen saturation of blood, oxygen consumption. 
Hemopoiesis: cells in peripheral blood and red bone marrow. Mass of circulating blood, volume of total erythrocytes volume, Fe-59 uptake by erythrocytes.
Late effects: mean life span of rats, LD50/480 (the dose from which 50% of rats die within 480 days after exposure).
|No information on individuals available for this study
19-6-99|n/a,n/a|Sequence:1, Age:n/a,Type:Pu-239 nitrate,Quantity:83,Unit:kilobecquerels per kilogram animal,Application:Injection, intratracheal, Remarks:6 d after gamma exposure|44 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Sacrifice-1, 3, 7 days, 0.5, 1, 2, 3, 4, 6, 10, 12 months (to investigate respiration and haemopoietic systems) and after spontaneous death (to estimate life span)
Respiratory functions: frequency, depth and minute volume, oxygen saturation of blood, oxygen consumption. 
Hemopoiesis: cells in peripheral blood and red bone marrow. Mass of circulating blood, volume of total erythrocytes volume, Fe-59 uptake by erythrocytes.
Late effects: mean life span of rats, LD50/480 (the dose from which 50% of rats die within 480 days after exposure).
|No information on individuals available for this study
19-6-100|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:1.86,Unit:grays,Application:External exposure, Remarks:n/a|43 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Sacrifice-1, 3, 7 days, 0.5, 1, 2, 3, 4, 6, 10, 12 months (to investigate respiration and haemopoietic systems) and after spontaneous death (to estimate life span)
Respiratory functions: frequency, depth and minute volume, oxygen saturation of blood, oxygen consumption. 
Hemopoiesis: cells in peripheral blood and red bone marrow. Mass of circulating blood, volume of total erythrocytes volume, Fe-59 uptake by erythrocytes.
Late effects: mean life span of rats, LD50/480 (the dose from which 50% of rats die within 480 days after exposure).
|No information on individuals available for this study
19-6-100|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 nitrate,Quantity:83,Unit:kilobecquerels per kilogram animal,Application:Injection, intratracheal, Remarks:6 d after gamma exposure|43 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Sacrifice-1, 3, 7 days, 0.5, 1, 2, 3, 4, 6, 10, 12 months (to investigate respiration and haemopoietic systems) and after spontaneous death (to estimate life span)
Respiratory functions: frequency, depth and minute volume, oxygen saturation of blood, oxygen consumption. 
Hemopoiesis: cells in peripheral blood and red bone marrow. Mass of circulating blood, volume of total erythrocytes volume, Fe-59 uptake by erythrocytes.
Late effects: mean life span of rats, LD50/480 (the dose from which 50% of rats die within 480 days after exposure).
|No information on individuals available for this study
19-6-101|n/a,n/a|Sequence:1, Age:n/a,Type:Pu-239 nitrate,Quantity:188,Unit:kilobecquerels per kilogram animal,Application:Injection, intratracheal, Remarks:immediately after exposure|38 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Sacrifice-1, 3, 7 days, 0.5, 1, 2, 3, 4, 6, 10, 12 months (to investigate respiration and haemopoietic systems) and after spontaneous death (to estimate life span)
Respiratory functions: frequency, depth and minute volume, oxygen saturation of blood, oxygen consumption. 
Hemopoiesis: cells in peripheral blood and red bone marrow. Mass of circulating blood, volume of total erythrocytes volume, Fe-59 uptake by erythrocytes.
Late effects: mean life span of rats, LD50/480 (the dose from which 50% of rats die within 480 days after exposure).
|No information on individuals available for this study
19-6-102|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:1.86,Unit:grays,Application:External exposure, Remarks:n/a|40 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Sacrifice-1, 3, 7 days, 0.5, 1, 2, 3, 4, 6, 10, 12 months (to investigate respiration and haemopoietic systems) and after spontaneous death (to estimate life span)
Respiratory functions: frequency, depth and minute volume, oxygen saturation of blood, oxygen consumption. 
Hemopoiesis: cells in peripheral blood and red bone marrow. Mass of circulating blood, volume of total erythrocytes volume, Fe-59 uptake by erythrocytes.
Late effects: mean life span of rats, LD50/480 (the dose from which 50% of rats die within 480 days after exposure).
|No information on individuals available for this study
19-6-102|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 nitrate,Quantity:188,Unit:kilobecquerels per kilogram animal,Application:Injection, intratracheal, Remarks:immediately after exposure|40 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Sacrifice-1, 3, 7 days, 0.5, 1, 2, 3, 4, 6, 10, 12 months (to investigate respiration and haemopoietic systems) and after spontaneous death (to estimate life span)
Respiratory functions: frequency, depth and minute volume, oxygen saturation of blood, oxygen consumption. 
Hemopoiesis: cells in peripheral blood and red bone marrow. Mass of circulating blood, volume of total erythrocytes volume, Fe-59 uptake by erythrocytes.
Late effects: mean life span of rats, LD50/480 (the dose from which 50% of rats die within 480 days after exposure).
|No information on individuals available for this study
19-6-103|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:3.72,Unit:grays,Application:External exposure, Remarks:n/a|25 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-103|n/a,n/a|Sequence:2, Age:n/a,Type:Np-237 nitrate,Quantity:18.5,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:immediately after exposure|25 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-104|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:3.72,Unit:grays,Application:External exposure, Remarks:n/a|17 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-104|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-238 nitrate,Quantity:18.5,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:immediately after exposure|17 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-105|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:3.72,Unit:grays,Application:External exposure, Remarks:n/a|17 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-105|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 nitrate,Quantity:18.5,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:immediately after exposure|17 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-106|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:3.72,Unit:grays,Application:External exposure, Remarks:n/a|23 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-106|n/a,n/a|Sequence:2, Age:n/a,Type:Am-241 (?chemical form),Quantity:18.5,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:immediately after exposure|23 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-107|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:1.86,Unit:grays,Application:External exposure, Remarks:n/a|19 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-107|n/a,n/a|Sequence:2, Age:n/a,Type:Np-237 nitrate,Quantity:18.5,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:immediately after exposure|19 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-108|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:1.86,Unit:grays,Application:External exposure, Remarks:n/a|26 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-108|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-238 nitrate,Quantity:18.5,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:immediately after exposure|26 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-109|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:1.86,Unit:grays,Application:External exposure, Remarks:n/a|23 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-109|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 nitrate,Quantity:18.5,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:immediately after exposure|23 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-110|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:1.86,Unit:grays,Application:External exposure, Remarks:n/a|22 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-110|n/a,n/a|Sequence:2, Age:n/a,Type:Am-241 (?chemical form),Quantity:18.5,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:immediately after exposure|22 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-111|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.93,Unit:grays,Application:External exposure, Remarks:n/a|20 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-111|n/a,n/a|Sequence:2, Age:n/a,Type:Np-237 nitrate,Quantity:18.5,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:immediately after exposure|20 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-112|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.93,Unit:grays,Application:External exposure, Remarks:n/a|18 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-112|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-237,Quantity:18.5,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:immediately after exposure|18 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-113|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.93,Unit:grays,Application:External exposure, Remarks:n/a|21 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-113|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 nitrate,Quantity:18.5,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:immediately after exposure|21 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-114|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.93,Unit:grays,Application:External exposure, Remarks:n/a|24 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-114|n/a,n/a|Sequence:2, Age:n/a,Type:Am-241 (?chemical form),Quantity:18.5,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:immediately after exposure|24 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-115|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.465,Unit:grays,Application:External exposure, Remarks:n/a|17 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-115|n/a,n/a|Sequence:2, Age:n/a,Type:Np-237 nitrate,Quantity:18.5,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:immediately after exposure|17 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-116|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.465,Unit:grays,Application:External exposure, Remarks:n/a|18 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-116|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-238 nitrate,Quantity:18.5,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:immediately after exposure|18 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-117|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.465,Unit:grays,Application:External exposure, Remarks:n/a|22 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-117|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 nitrate,Quantity:18.5,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:immediately after exposure|22 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-118|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.465,Unit:grays,Application:External exposure, Remarks:n/a|19 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-118|n/a,n/a|Sequence:2, Age:n/a,Type:Am-241 (?chemical form),Quantity:18.5,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:immediately after exposure|19 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-119|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.23,Unit:grays,Application:External exposure, Remarks:n/a|19 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-119|n/a,n/a|Sequence:2, Age:n/a,Type:Np-237 nitrate,Quantity:18.5,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:immediately after exposure|19 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-120|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.23,Unit:grays,Application:External exposure, Remarks:n/a|21 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-120|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-238 nitrate,Quantity:18.5,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:immediately after exposure|21 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-121|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.23,Unit:grays,Application:External exposure, Remarks:n/a|21 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-121|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 nitrate,Quantity:18.5,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:immediately after exposure|21 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-122|n/a,n/a|Sequence:1, Age:n/a,Type:gamma-rays Cs-137,Quantity:0.23,Unit:grays,Application:External exposure, Remarks:n/a|21 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-122|n/a,n/a|Sequence:2, Age:n/a,Type:Am-241 (?chemical form),Quantity:18.5,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:immediately after exposure|21 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-123|n/a,n/a|Sequence:1, Age:n/a,Type:none (controls),Quantity:0,Unit:grays,Application:External exposure, Remarks:n/a|139 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data). Average life span.
|No information on individuals available for this study
19-6-124|n/a,n/a|Sequence:1, Age:n/a,Type:U-238,Quantity:4,Unit:percent in food,Application:Injection, intravenous, Remarks:n/a|19 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-125|n/a,n/a|Sequence:1, Age:n/a,Type:U-238,Quantity:8,Unit:percent in food,Application:Injection, intravenous, Remarks:n/a|46 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-126|n/a,n/a|Sequence:1, Age:n/a,Type:U-238,Quantity:8,Unit:percent in food,Application:Injection, intravenous, Remarks:n/a|54 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-126|n/a,n/a|Sequence:2, Age:n/a,Type:Np-237 nitrate,Quantity:5.5,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:simultaneously|54 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-127|n/a,n/a|Sequence:1, Age:n/a,Type:U-238,Quantity:8,Unit:percent in food,Application:Injection, intravenous, Remarks:n/a|54 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-127|n/a,n/a|Sequence:2, Age:n/a,Type:Np-237 nitrate,Quantity:11.1,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:simultaneously|54 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-128|n/a,n/a|Sequence:1, Age:n/a,Type:U-238,Quantity:8,Unit:percent in food,Application:Injection, intravenous, Remarks:n/a|54 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-128|n/a,n/a|Sequence:2, Age:n/a,Type:Np-237 nitrate,Quantity:22.2,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:simultaneously|54 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-129|n/a,n/a|Sequence:1, Age:n/a,Type:U-238,Quantity:8,Unit:percent in food,Application:Injection, intravenous, Remarks:n/a|55 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-129|n/a,n/a|Sequence:2, Age:n/a,Type:Np-237 nitrate,Quantity:46.3,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:simultaneously|55 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-130|n/a,n/a|Sequence:1, Age:n/a,Type:U-238,Quantity:8,Unit:percent in food,Application:Injection, intravenous, Remarks:n/a|55 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-130|n/a,n/a|Sequence:2, Age:n/a,Type:Np-237 nitrate,Quantity:92.5,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:simultaneously|55 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-131|n/a,n/a|Sequence:1, Age:n/a,Type:U-238,Quantity:8,Unit:percent in food,Application:Injection, intravenous, Remarks:n/a|35 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-131|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-238 nitrate,Quantity:5.5,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:simultaneously|35 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-132|n/a,n/a|Sequence:1, Age:n/a,Type:U-238,Quantity:8,Unit:percent in food,Application:Injection, intravenous, Remarks:n/a|35 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-132|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-238 nitrate,Quantity:11.1,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:simultaneously|35 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-133|n/a,n/a|Sequence:1, Age:n/a,Type:U-238,Quantity:8,Unit:percent in food,Application:Injection, intravenous, Remarks:n/a|35 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-133|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-238 nitrate,Quantity:22.2,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:simultaneously|35 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-134|n/a,n/a|Sequence:1, Age:n/a,Type:U-238,Quantity:8,Unit:percent in food,Application:Injection, intravenous, Remarks:n/a|35 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-134|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-238 nitrate,Quantity:46.3,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:simultaneously|35 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-135|n/a,n/a|Sequence:1, Age:n/a,Type:U-238,Quantity:8,Unit:percent in food,Application:Injection, intravenous, Remarks:n/a|35 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-135|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-238 nitrate,Quantity:92.5,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:simultaneously|35 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-136|n/a,n/a|Sequence:1, Age:n/a,Type:U-238,Quantity:8,Unit:percent in food,Application:Injection, intravenous, Remarks:n/a|40 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-136|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 nitrate,Quantity:5.5,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:simultaneously|40 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-137|n/a,n/a|Sequence:1, Age:n/a,Type:U-238,Quantity:8,Unit:percent in food,Application:Injection, intravenous, Remarks:n/a|39 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-137|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 nitrate,Quantity:11.1,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:simultaneously|39 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-138|n/a,n/a|Sequence:1, Age:n/a,Type:U-238,Quantity:8,Unit:percent in food,Application:Injection, intravenous, Remarks:n/a|39 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-138|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 nitrate,Quantity:22.2,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:simultaneously|39 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-139|n/a,n/a|Sequence:1, Age:n/a,Type:U-238,Quantity:8,Unit:percent in food,Application:Injection, intravenous, Remarks:n/a|39 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-139|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 nitrate,Quantity:46.3,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:simultaneously|39 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-140|n/a,n/a|Sequence:1, Age:n/a,Type:U-238,Quantity:8,Unit:percent in food,Application:Injection, intravenous, Remarks:n/a|39 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-140|n/a,n/a|Sequence:2, Age:n/a,Type:Pu-239 nitrate,Quantity:92.5,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:simultaneously|39 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-141|n/a,n/a|Sequence:1, Age:n/a,Type:U-238,Quantity:8,Unit:percent in food,Application:Injection, intravenous, Remarks:n/a|30 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-141|n/a,n/a|Sequence:2, Age:n/a,Type:Am-241 (?chemical form),Quantity:5.5,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:simultaneously|30 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-142|n/a,n/a|Sequence:1, Age:n/a,Type:U-238,Quantity:8,Unit:percent in food,Application:Injection, intravenous, Remarks:n/a|29 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-142|n/a,n/a|Sequence:2, Age:n/a,Type:Am-241 (?chemical form),Quantity:11.1,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:simultaneously|29 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-143|n/a,n/a|Sequence:1, Age:n/a,Type:U-238,Quantity:8,Unit:percent in food,Application:Injection, intravenous, Remarks:n/a|29 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-143|n/a,n/a|Sequence:2, Age:n/a,Type:Am-241 (?chemical form),Quantity:22.2,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:simultaneously|29 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-144|n/a,n/a|Sequence:1, Age:n/a,Type:U-238,Quantity:8,Unit:percent in food,Application:Injection, intravenous, Remarks:n/a|29 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-144|n/a,n/a|Sequence:2, Age:n/a,Type:Am-241 (?chemical form),Quantity:46.3,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:simultaneously|29 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-145|n/a,n/a|Sequence:1, Age:n/a,Type:U-238,Quantity:8,Unit:percent in food,Application:Injection, intravenous, Remarks:n/a|29 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
19-6-145|n/a,n/a|Sequence:2, Age:n/a,Type:Am-241 (?chemical form),Quantity:92.5,Unit:kilobecquerels per kilogram animal,Application:Injection, intravenous, Remarks:simultaneously|29 (0 in ERA)|Rat|Rat Wistar|n/a|Unknown|Late effects: inflammatory, dystrophic, sclerotic and neoplastic changes in organs after spontaneous death (histological data).
|No information on individuals available for this study
		
